CN101091706A - 多巴胺转运蛋白激动剂及其用途 - Google Patents
多巴胺转运蛋白激动剂及其用途 Download PDFInfo
- Publication number
- CN101091706A CN101091706A CNA2006100280686A CN200610028068A CN101091706A CN 101091706 A CN101091706 A CN 101091706A CN A2006100280686 A CNA2006100280686 A CN A2006100280686A CN 200610028068 A CN200610028068 A CN 200610028068A CN 101091706 A CN101091706 A CN 101091706A
- Authority
- CN
- China
- Prior art keywords
- dopamine
- nervous system
- psychotic disorder
- system disease
- excitant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
化合物 | 3H-DA摄取 | 3H-GABA摄取 | ||
CHO | D8 | CHO | G-1 | |
HBS芹菜索木犀草素乙酰化SZ92大豆甙元槲皮素染料木索 | 0.080.020.010.040.020.030.05 | 1.001.804.301.972.891.451.65 | 0.010.030.020.040.030.040.05 | 1.000.981.041.001.021.011.02 |
症状 | 条件 | 记分 | |
行为表现 | 异常姿势**高度激惹**咬牙** | 能碰靠近间断性连续性 | 2120.51 |
植物神经系症状 | 流泪*腹泻*流涎* | 软便不成形轻度明显 | 44812 |
体重减轻 | <2%<4%<6%<8%>=8% | 05101520 |
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100280686A CN101091706B (zh) | 2006-06-23 | 2006-06-23 | 多巴胺转运蛋白激动剂及其用途 |
PCT/CN2007/001839 WO2008000142A1 (fr) | 2006-06-23 | 2007-06-11 | Agoniste du transporteur de la dopamine et ses utilisations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100280686A CN101091706B (zh) | 2006-06-23 | 2006-06-23 | 多巴胺转运蛋白激动剂及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101091706A true CN101091706A (zh) | 2007-12-26 |
CN101091706B CN101091706B (zh) | 2011-05-04 |
Family
ID=38845113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100280686A Expired - Fee Related CN101091706B (zh) | 2006-06-23 | 2006-06-23 | 多巴胺转运蛋白激动剂及其用途 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101091706B (zh) |
WO (1) | WO2008000142A1 (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101591319B (zh) * | 2009-06-22 | 2011-12-21 | 复旦大学 | 黄酮类衍生物及其在制备药物组合物中的用途 |
CN102716118A (zh) * | 2011-03-29 | 2012-10-10 | 复旦大学 | 金雀异黄素及其衍生物在制备催眠类药物中的用途 |
CN103674812A (zh) * | 2012-08-31 | 2014-03-26 | 波音公司 | 固体、气雾剂、蒸汽、液体和气体的浓度以及颗粒大小的测量 |
CN103655540A (zh) * | 2012-09-26 | 2014-03-26 | 四川大学华西医院 | 杨梅素晶体化合物用于神经抑制剂的药物的应用 |
CN104873485A (zh) * | 2015-05-08 | 2015-09-02 | 中国药科大学 | 槲皮素治疗与胃肠道应激失调相关疾病的用途 |
CN106244548A (zh) * | 2015-06-09 | 2016-12-21 | 成都中医药大学 | 木犀草素在诱导间充质干细胞向神经细胞定向分化中的用途 |
CN106963754A (zh) * | 2017-02-17 | 2017-07-21 | 深圳市太空科技南方研究院 | 木犀草素及其类似物用于调节生物节律的用途 |
CN107099435A (zh) * | 2017-06-30 | 2017-08-29 | 青岛河澄知识产权有限公司 | 一种缓解更年期不适症的含酒精组合物 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120029066A1 (en) * | 2010-07-30 | 2012-02-02 | Taipei Medical University | Use of flavones for treating psychiatric disorders with sensorimotor gating deficits |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169822C (zh) * | 1999-09-17 | 2004-10-06 | 中国人民解放军军事医学科学院毒物药物研究所 | 槲皮素衍生物及其医药用途 |
US20010047032A1 (en) * | 1999-12-30 | 2001-11-29 | Castillo Gerardo M. | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
JP2001213775A (ja) * | 2000-02-03 | 2001-08-07 | Pola Chem Ind Inc | ストレス軽減剤及びそれを含有してなる皮膚外用剤 |
EP1127572A3 (en) * | 2000-02-25 | 2003-05-02 | Basf Aktiengesellschaft | Use of flavones for treating cycloxygenase-2 mediated diseases |
EP1377286A1 (en) * | 2001-02-20 | 2004-01-07 | Randy H. Ziegler | Treatment of schizophrenia |
CN1193750C (zh) * | 2001-10-26 | 2005-03-23 | 牛建昭 | 一种治疗更年期综合症的药物 |
CN1216878C (zh) * | 2002-06-28 | 2005-08-31 | 陕西九州科技股份有限公司 | 染料木素的制备工艺 |
AU2002333157A1 (en) * | 2002-09-03 | 2004-03-29 | Naturon Limited | Compound for treatment of anxiety and methods of preparation and use thereof |
-
2006
- 2006-06-23 CN CN2006100280686A patent/CN101091706B/zh not_active Expired - Fee Related
-
2007
- 2007-06-11 WO PCT/CN2007/001839 patent/WO2008000142A1/zh active Application Filing
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101591319B (zh) * | 2009-06-22 | 2011-12-21 | 复旦大学 | 黄酮类衍生物及其在制备药物组合物中的用途 |
CN102716118A (zh) * | 2011-03-29 | 2012-10-10 | 复旦大学 | 金雀异黄素及其衍生物在制备催眠类药物中的用途 |
CN103674812A (zh) * | 2012-08-31 | 2014-03-26 | 波音公司 | 固体、气雾剂、蒸汽、液体和气体的浓度以及颗粒大小的测量 |
CN103655540A (zh) * | 2012-09-26 | 2014-03-26 | 四川大学华西医院 | 杨梅素晶体化合物用于神经抑制剂的药物的应用 |
CN104873485A (zh) * | 2015-05-08 | 2015-09-02 | 中国药科大学 | 槲皮素治疗与胃肠道应激失调相关疾病的用途 |
CN104873485B (zh) * | 2015-05-08 | 2019-02-19 | 中国药科大学 | 槲皮素治疗与胃肠道应激失调相关疾病的用途 |
CN106244548A (zh) * | 2015-06-09 | 2016-12-21 | 成都中医药大学 | 木犀草素在诱导间充质干细胞向神经细胞定向分化中的用途 |
CN106244548B (zh) * | 2015-06-09 | 2019-07-05 | 成都中医药大学 | 木犀草素在诱导间充质干细胞向神经细胞定向分化中的用途 |
CN106963754A (zh) * | 2017-02-17 | 2017-07-21 | 深圳市太空科技南方研究院 | 木犀草素及其类似物用于调节生物节律的用途 |
CN106963754B (zh) * | 2017-02-17 | 2021-05-04 | 深圳市太空科技南方研究院 | 木犀草素及其类似物用于调节生物节律的用途 |
CN107099435A (zh) * | 2017-06-30 | 2017-08-29 | 青岛河澄知识产权有限公司 | 一种缓解更年期不适症的含酒精组合物 |
Also Published As
Publication number | Publication date |
---|---|
WO2008000142A1 (fr) | 2008-01-03 |
CN101091706B (zh) | 2011-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101091706B (zh) | 多巴胺转运蛋白激动剂及其用途 | |
Lakstygal et al. | Dark classics in chemical neuroscience: atropine, scopolamine, and other anticholinergic deliriant hallucinogens | |
CN100502858C (zh) | 柚皮素及其衍生物用于制备抗心脑系统疾病产品的用途 | |
RU2334514C1 (ru) | СРЕДСТВО ДЛЯ УЛУЧШЕНИЯ КОГНИТИВНЫХ ФУНКЦИЙ И ПАМЯТИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО (4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ | |
CN102143744B (zh) | 7,8-二羟基黄酮及其衍生物在制备治疗抑郁的药物中的用途 | |
CN102159215B (zh) | 使用TrkB激动剂治疗各种病症 | |
CN101411716B (zh) | 虎杖苷用于制备抗痴呆产品的用途 | |
CN109890371A (zh) | 组合物及其方法 | |
CN102274227B (zh) | 粉防己碱在制备预防和/或治疗抑郁症药物中的应用 | |
CN104968339A (zh) | 用于治疗神经变性疾病的方法和组合物 | |
CN105998014A (zh) | 去氢骆驼蓬碱衍生物作为制备治疗囊型包虫病药物的应用 | |
US9023788B2 (en) | Methods compounds and pharmaceutical compositions for treating anxiety and mood disorders | |
Graves et al. | The atypical antidepressant mirtazapine attenuates expression of morphine-induced place preference and motor sensitization | |
CN108553456A (zh) | 苯甲酸及其衍生物的新用途 | |
CN102125575A (zh) | 芍药内酯苷的抗帕金森症用途 | |
Modell et al. | Dopaminergic activity of the antimuscarinic antiparkinsonian agents | |
Zhao et al. | Bakuchiol analogs inhibit monoamine transporters and regulate monoaminergic functions | |
Zhao et al. | Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter | |
KR101399513B1 (ko) | 과민성 장 증후군의 예방 또는 치료용 조성물 | |
US8530525B2 (en) | Methods and compositions for protecting and treating neuroinjury | |
US11396510B2 (en) | GABAA receptor ligand | |
Hallam et al. | An investigation of the effect of tacrine and physostigmine on spatial working memory deficits in the olfactory bulbectomised rat | |
CN101642465B (zh) | 广东海风藤多糖在制备预防和/或治疗老年性痴呆症药物中的应用 | |
Rao et al. | In vivo pharmacological characterization of (±)-4-[2-(1-methyl-2-pyrrolidinyl) ethyl] thiophenol hydrochloride (SIB-1553A), a novel cholinergic ligand: microdialysis studies | |
Narita et al. | Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SINO-AMERICAN GUOLIAN (SHANGHAI) BIOTECHNOLOGY RES Free format text: FORMER OWNER: HEHONG BIO-TECH (SHANGHAI) CO., LTD. Effective date: 20120213 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201203 PUDONG NEW AREA, SHANGHAI TO: 200333 PUTUO, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120213 Address after: 200333, building 15, building 879, No. 4, Zhongjiang Road, Shanghai, Putuo District Patentee after: Guolian (Shanghai) Biotechnology Research Co., Ltd. Address before: Pudong New Area Zhangjiang High Tech Park of Shanghai City, No. 351 GuoShouJing road 201203 Patentee before: Hehong Biotechnology (Shanghai) Co., Ltd. |
|
C56 | Change in the name or address of the patentee |
Owner name: SHANGHAI UNITED STEM CELL TECHNOLOGY CO., LTD. Free format text: FORMER NAME: ZHONGMEI GUOLIAN (SHANGHAI) BIOTECHNOLOGY RESEARCH CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 200333, building 15, building 879, No. 4, Zhongjiang Road, Shanghai, Putuo District Patentee after: Shanghai United Stem Cell Technology Co., Ltd. Address before: 200333, building 15, building 879, No. 4, Zhongjiang Road, Shanghai, Putuo District Patentee before: Guolian (Shanghai) Biotechnology Research Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110504 Termination date: 20160623 |
|
CF01 | Termination of patent right due to non-payment of annual fee |